Fulcrum Therapeutics Inc (NASDAQ:FULC)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - FULC
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - FULC
- Market Cap$440.930m
- SymbolNASDAQ:FULC
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS3596161097
Company Profile
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability.
Latest FULC news
Currently there for this company. Visit our news hub for other news .